Knee Arthritis and Fibromyalgia — Significant Pain Reduction and Functional Recovery
Degenerative Knee Arthritis and Fibromyalgia

Patient
Daniela
Origin
Italy
Diagnosis
Degenerative knee arthritis (post-surgical) and fibromyalgia
Treatment
July 2023
Author
Dr. Uladzislau Tsvirko
Patient Background
Daniela, a patient from Italy, presented with chronic knee arthritis that persisted even after a prior surgical intervention. Despite undergoing surgery, she continued to experience joint pain, reduced mobility, and functional discomfort affecting daily activities. In addition to the knee condition, she reported symptoms consistent with fibromyalgia, including widespread musculoskeletal pain that had been present for an extended period. These symptoms impacted her overall physical wellbeing and quality of life. At the time of evaluation at BioCells Medical, her primary concerns were persistent knee dysfunction and chronic systemic pain.
Treatment Protocol
- •Autologous mesenchymal stem cells (MSCs)
- •Concentrated purified exosomes
- •Combined systemic (intravenous) and local intra-articular administration into the knee joint
- •Continuous medical supervision during the treatment process
- •Protocol informed by clinical evaluation, surgical history, and systemic inflammatory assessment
Reported Functional Changes
- •Marked reduction in knee pain
- •Significant improvement in joint mobility
- •Near-complete functional recovery of the affected knee
- •Substantial decrease in fibromyalgia-related pain intensity
- •Improved overall physical wellbeing and sustained improvement in mobility
- •Patient reported feeling well at a general level, with improved quality of life
Video Observation
Follow-up and Ongoing Monitoring
Daniela remains under medical follow-up to monitor joint stability, functional capacity, and systemic symptom progression. Future therapeutic decisions are considered based on clinical evolution, objective assessment, and patient-specific goals.
Clinical Context
This case illustrates potential functional improvements following a personalised regenerative medicine protocol in a patient with degenerative joint pathology and systemic pain syndrome. At BioCells Medical, each protocol is individually designed according to the patient's diagnosis, previous interventions, stage of condition, and overall medical profile. Continuous supervision and structured follow-up are integral components of the treatment process.
Note: All observations reported in this case are based on post-treatment follow-up communication with the patient's family and clinical team. Individual results vary. This case does not constitute a clinical trial and should not be interpreted as a guarantee of outcome.